258 related articles for article (PubMed ID: 1583867)
1. Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.
Treacy E; Clow CL; Reade TR; Chitayat D; Mamer OA; Scriver CR
J Inherit Metab Dis; 1992; 15(1):121-35. PubMed ID: 1583867
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
[TBL] [Abstract][Full Text] [Related]
3. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
Schadewaldt P; Hammen HW; Ott AC; Wendel U
J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
5. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
6. Thiamin-responsive maple syrup urine disease: seizures after 7 years of satisfactory metabolic control.
Delis D; Michelakakis H; Katsarou E; Bartsocas CS
J Inherit Metab Dis; 2001 Nov; 24(6):683-4. PubMed ID: 11768588
[No Abstract] [Full Text] [Related]
7. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
Snyderman SE; Goldstein F; Sansaricq C; Norton PM
Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
[TBL] [Abstract][Full Text] [Related]
8. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
[TBL] [Abstract][Full Text] [Related]
9. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
[TBL] [Abstract][Full Text] [Related]
10. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
11. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
Schadewaldt P; Wendel U
Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
[TBL] [Abstract][Full Text] [Related]
12. So-called thiamin-responsive maple syrup urine disease: 15-year follow-up of the original patient.
Scriver CR; Clow CL; George H
J Pediatr; 1985 Nov; 107(5):763-5. PubMed ID: 4056978
[No Abstract] [Full Text] [Related]
13. Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease.
Campuzano-García AE; Castanedo-Cázares JP
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738841
[TBL] [Abstract][Full Text] [Related]
14. [3 patients with maple syrup urine disease].
Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
[TBL] [Abstract][Full Text] [Related]
15. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
[TBL] [Abstract][Full Text] [Related]
16. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
Sowell J; Pollard L; Wood T
J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
[TBL] [Abstract][Full Text] [Related]
17. Maple syrup urine disease variant form: presentation with psychomotor retardation and CT scan abnormalities.
Verdu A; Lopez-Herce J; Pascual-Castroviejo I; Martinez-Bermejo A; Ugarte M; Garcia MJ
Acta Paediatr Scand; 1985 Sep; 74(5):815-8. PubMed ID: 4050430
[TBL] [Abstract][Full Text] [Related]
18. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
[TBL] [Abstract][Full Text] [Related]
19. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
[TBL] [Abstract][Full Text] [Related]
20. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.
Wajner M; Coelho DM; Barschak AG; Araújo PR; Pires RF; Lulhier FL; Vargas CR
J Inherit Metab Dis; 2000 Jul; 23(5):505-12. PubMed ID: 10947205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
